Bio Green Med Solution Form 4: 108,107 shares sold at $3.088

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) reported an insider transaction on Form 4. On 10/20/2025, 10% owner Datuk Tan Chor How Christopher sold 108,107 shares of common stock at $3.088 per share (Transaction Code: S). Following the sale, the reporting person beneficially owns 371,600 shares, held directly.

Insider Trade Summary

Net Seller: 108,107 shares

Net Sell 1 txn

Insider FITTERS Diversified Berhad

Role 10% Owner

Sold 108,107 shs ($334K)

Type	Security	Shares	Price	Value
Sale	Common Stock	108,107	$3.088	$334K

Holdings After Transaction: Common Stock — 371,600 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 10/22/2025 - 06:00 PM Learn about SEC filing dates

FAQ

What did BGMS disclose in this Form 4 filing?

A sale of 108,107 shares of BGMS common stock on 10/20/2025 at $3.088 per share by a reporting person.

Who is the BGMS insider involved and what is their role?

The reporting person is Datuk Tan Chor How Christopher, identified as a 10% owner.

How many BGMS shares does the insider hold after the transaction?

The insider beneficially owns 371,600 shares following the reported sale.

What was the transaction code and what does it indicate?

The transaction code was S, indicating an open market or private sale of non-derivative securities.

What is the ownership form of the remaining BGMS shares?

The remaining 371,600 shares are held directly by the reporting person.

What class of security was involved?

The transaction involved common stock of Bio Green Med Solution, Inc. (BGMS).

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FITTERS Diversified Berhad

(Last) (First) (Middle)

NO. 1, JALAN TEMBAGA SD 5/2

BANDAR SRI DAMANSARA

(Street)

KUALA LUMPUR N8 52200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/20/2025		S		108,107	D	$3.088	371,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Datuk Tan Chor How Christopher	10/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.